<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">antibiotics</journal-id><journal-title-group><journal-title xml:lang="ru">Антибиотики и Химиотерапия</journal-title><trans-title-group xml:lang="en"><trans-title>Antibiot Khimioter = Antibiotics and Chemotherapy</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0235-2990</issn><publisher><publisher-name>ООО «Издательство ОКИ»</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">antibiotics-297</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>В ПОМОЩЬ ПРАКТИКУЮЩЕМУ ВРАЧУ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>GUIDELINES FOR PRACTITIONERS</subject></subj-group></article-categories><title-group><article-title>Этиотропная лекарственная терапия распространённых и социально значимых вирусных инфекций человека</article-title><trans-title-group xml:lang="en"><trans-title>Etiotropic Drug Therapy of Prevailing and Socially Significant Human Viral Infections</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Васильев</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Vasilyev</surname><given-names>A. N.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Институт доклинической и клинической экспертизы лекарственных средств ФГУ «Научный центр экспертизы средств медицинского применения» Росздравнадзора, Москва</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Scientific Centre for Examination of Medicinal Products, Institute for Preclinical and Clinical Investigation of Drugs, Moscow</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2010</year></pub-date><pub-date pub-type="epub"><day>13</day><month>05</month><year>2020</year></pub-date><volume>55</volume><issue>3-4</issue><fpage>29</fpage><lpage>34</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; ООО «Издательство ОКИ», 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">ООО «Издательство ОКИ»</copyright-holder><copyright-holder xml:lang="en">ООО «Издательство ОКИ»</copyright-holder><license xlink:href="https://www.antibiotics-chemotherapy.ru/jour/about/submissions#copyrightNotice" xlink:type="simple"><license-p>https://www.antibiotics-chemotherapy.ru/jour/about/submissions#copyrightNotice</license-p></license></permissions><self-uri xlink:href="https://www.antibiotics-chemotherapy.ru/jour/article/view/297">https://www.antibiotics-chemotherapy.ru/jour/article/view/297</self-uri></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">DeClercq E. In search of effective antiviral agents. J Clin Virol 2006; 37: 82-86.</mixed-citation><mixed-citation xml:lang="en">DeClercq E. In search of effective antiviral agents. J Clin Virol 2006; 37: 82-86.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Львов Д. К., Колобухина Л. В. Роль вирусов в инфекционной патологии. Медицинская вирусология / ред. Д. К. Львов, М.: 2008; 21-41.</mixed-citation><mixed-citation xml:lang="en">Львов Д. К., Колобухина Л. В. Роль вирусов в инфекционной патологии. Медицинская вирусология / ред. Д. К. Львов, М.: 2008; 21-41.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ершов Ф. И., Киселев О. В. Интерфероны и их индукторы, М.: 2005.</mixed-citation><mixed-citation xml:lang="en">Ершов Ф. И., Киселев О. В. Интерфероны и их индукторы, М.: 2005.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Richman D. D. Antiviral drug resistance: issue and challengers. Antiv Drug Res; 1996; 29: 1: 31-33.</mixed-citation><mixed-citation xml:lang="en">Richman D. D. Antiviral drug resistance: issue and challengers. Antiv Drug Res; 1996; 29: 1: 31-33.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Каверин Н. В. Генетические взаимодействия вирусов. Медицинская вирусология / ред. Д. К. Львов, М.: 2008; 68-73.</mixed-citation><mixed-citation xml:lang="en">Каверин Н. В. Генетические взаимодействия вирусов. Медицинская вирусология / ред. Д. К. Львов, М.: 2008; 68-73.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ленева И. А., Шустер А. М. Противовирусные этиотропные препараты: эффективность против вируса гриппа А подтипа H5N1. Вопросы вирусологии. 2006; 5: 4-7.</mixed-citation><mixed-citation xml:lang="en">Ленева И. А., Шустер А. М. Противовирусные этиотропные препараты: эффективность против вируса гриппа А подтипа H5N1. Вопросы вирусологии. 2006; 5: 4-7.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Gubareva L., Kaiser L., Hayden F. G. Influenza virus neuraminidase inhibitors. Lancet 2000; 355: 9206: 827-835.</mixed-citation><mixed-citation xml:lang="en">Gubareva L., Kaiser L., Hayden F. G. Influenza virus neuraminidase inhibitors. Lancet 2000; 355: 9206: 827-835.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu-Nan Li, Steinheuer D. A. The mechanism and inhibition of influenza virus. J. Entry Viral Entry 2006; 2: 2: 57-66.</mixed-citation><mixed-citation xml:lang="en">Zhu-Nan Li, Steinheuer D. A. The mechanism and inhibition of influenza virus. J. Entry Viral Entry 2006; 2: 2: 57-66.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Галегов Г. А., Андронова В. Л. Химиотерапия вирусных инфекций. Медицинская вирусология / ред. Д. К. Львов, М.: 2008; 87-92.</mixed-citation><mixed-citation xml:lang="en">Галегов Г. А., Андронова В. Л. Химиотерапия вирусных инфекций. Медицинская вирусология / ред. Д. К. Львов, М.: 2008; 87-92.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Ribavirin as Broad Spectrum Antiviral Compound / Ed. R. Sidwell. New York, 1986.</mixed-citation><mixed-citation xml:lang="en">Ribavirin as Broad Spectrum Antiviral Compound / Ed. R. Sidwell. New York, 1986.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">De Clercq E. Antiviral drugs in current clinical use. J Clin Virol 2005; 31: 115-130.</mixed-citation><mixed-citation xml:lang="en">De Clercq E. Antiviral drugs in current clinical use. J Clin Virol 2005; 31: 115-130.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Corey L. Acyclovir for the treatment of oral, facial, and genital Herpes simplex virus infections. Antiv Chemother Elsevier 1987; 167-174.</mixed-citation><mixed-citation xml:lang="en">Corey L. Acyclovir for the treatment of oral, facial, and genital Herpes simplex virus infections. Antiv Chemother Elsevier 1987; 167-174.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">De Clercq E. Antiviral drugs, current state of the art. J Clin Virol 2001; 22: 73-89.</mixed-citation><mixed-citation xml:lang="en">De Clercq E. Antiviral drugs, current state of the art. J Clin Virol 2001; 22: 73-89.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">De Clercq E. New inhibitors of human cytomegalovirus (HCMV) on the horison. J Antimicrob Chemother 2003; 51: 1079-1083.</mixed-citation><mixed-citation xml:lang="en">De Clercq E. New inhibitors of human cytomegalovirus (HCMV) on the horison. J Antimicrob Chemother 2003; 51: 1079-1083.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">HIV Resistance and Implication for Therapy / Ed. B. Larder, MEDICOM 2000.</mixed-citation><mixed-citation xml:lang="en">HIV Resistance and Implication for Therapy / Ed. B. Larder, MEDICOM 2000.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Антиретровирусная терапия в России. / Ред. В. В. Покровский, Москва, 2007.</mixed-citation><mixed-citation xml:lang="en">Антиретровирусная терапия в России. / Ред. В. В. Покровский, Москва, 2007.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Burtlett J. G., Gallant J. E. Medical management of HIV infection. J. Hopkins University School of Medicine, 2005.</mixed-citation><mixed-citation xml:lang="en">Burtlett J. G., Gallant J. E. Medical management of HIV infection. J. Hopkins University School of Medicine, 2005.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Формулярное руководство по использованию лекарственных средств / Ред. Чучалин А. Г., Белоусов Ю. Б., Яснецов В. В. М.: 2009; вып 10.</mixed-citation><mixed-citation xml:lang="en">Формулярное руководство по использованию лекарственных средств / Ред. Чучалин А. Г., Белоусов Ю. Б., Яснецов В. В. М.: 2009; вып 10.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
